Dmitry Balyasny’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Sell
5,874
-293,081
-98% -$12.3M ﹤0.01% 2664
2026
Q1
$9.63M Buy
+298,955
New +$11.1M 0.01% 1050
2025
Q4
Sell
-29,965
Closed -$1.03M 3591
2025
Q3
$1.03M Sell
29,965
-140,283
-82% -$4.02M ﹤0.01% 2105
2025
Q2
$4.6M Buy
+170,248
New +$4.93M 0.01% 1328
2023
Q4
Sell
-102,178
Closed -$2.28M 2938
2023
Q3
$2.28M Buy
102,178
+79,741
+355% +$2.05M ﹤0.01% 1342
2023
Q2
$571K Sell
22,437
-27,103
-55% -$657K ﹤0.01% 1808
2023
Q1
$1.1M Buy
49,540
+49,373
+29,565% +$1.19M ﹤0.01% 1705
2022
Q4
$3.96K Sell
167
-17,932
-99% -$417K ﹤0.01% 2641
2022
Q3
$301K Buy
+18,099
New +$407K ﹤0.01% 2195
2022
Q1
Sell
-192,536
Closed -$7.93M 2873
2021
Q4
$7.93M Sell
192,536
-30,976
-14% -$1.37M 0.03% 705
2021
Q3
$10.4M Buy
+223,512
New +$9.75M 0.04% 564
2020
Q4
Sell
-220,952
Closed -$7.18M 1726
2020
Q3
$7.18M Sell
220,952
-36,537
-14% -$1.16M 0.05% 496
2020
Q2
$6.67M Buy
+257,489
New +$6.42M 0.06% 439

Other funds holding VCYT

Dmitry Balyasny's VCYT Position: Q2 2026 in Review

Dmitry Balyasny reduced its Veracyte (VCYT) stake by 98% in Q2 2026, selling an estimated $12.3M and leaving 5,874 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

Dmitry Balyasny first reported a position in VCYT in Q2 2020 and has held it in 13 quarters since. The position peaked at $10.4M in Q3 2021. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Dmitry Balyasny held 5,874 shares of Veracyte worth $345K as of Q2 2026.
  • Dmitry Balyasny sold 293,081 Veracyte shares in Q2 2026, an estimated $12.3M.
  • Veracyte made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2664 holding.
  • Dmitry Balyasny first reported a position in Veracyte in Q2 2020 and has held it in 13 quarters since.
  • Dmitry Balyasny's Veracyte position peaked at $10.4M in Q3 2021.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.